Hofseth BioCare ASA

HBC

NO0010598683

Food Processing

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-05-15 am EDT			5-day change	1st Jan Change
2.23 ^NOK	0.00%		+6.70%	-14.89%

Mar. 14	Hofseth BioCare ASA Announces Board Changes	CI
Feb. 09	Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Hofseth Biocare ASA Hires Andy Gill as VP from January 2021

November 30, 2020 at 02:52 am EST

Hofseth Biocare ASA announced the hiring of Andy Gill as VP within HBC’s Consumer Health Division from January 2021. Gill is a accomplished commercial leader with over 20 years’ experience in driving growth in the Healthcare and FMCG industries. Gill´s role will help and complement HBC´s engagement with specialised distributors B2B with global reach and its direct sales efforts B2C via online platforms and the Hofseth Group´s established retail network.

Latest news about Hofseth BioCare ASA

Hofseth BioCare ASA Announces Board Changes	Mar. 14	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 09	CI
Hofseth BioCare ASA Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 09	CI
Hofseth BioCare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
Hofseth BioCare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
Hofseth BioCare Secures Seed Funding for Pre-clinical Study of Prostate Cancer Treatment	23-08-17	MT
Aqua Bio Technology Asa Announces Distribution Agreement with Hofseth Biocare Asa	23-07-12	CI
Hofseth Biocare ASA Announces the Online Publication of Its Abstract	23-05-29	CI
Norway’s Hofseth Biocare Moves Prostate Cancer Co-treatment Project to US Entity	23-05-15	MT
Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Hofseth BioCare ASA Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Hofseth BioCare ASA Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-10	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-10	CI
Hofseth BioCare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Hofseth BioCare Says Preclinical Trial Shows ProGo Peptides Support Gut Health	22-10-17	MT
Hofseth BioCare ASA's Progo Bioactive Peptides Now Is A "New Dietary Ingredient" for the US FDA	22-08-28	CI
Hofseth BioCare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Hofseth Biocare Appoints CFO as CEO	22-07-29	MT
Hofseth BioCare ASA Announces Executive Changes	22-07-29	CI
Hofseth BioCare ASA announced that it has received NOK 1.4196 billion in funding	22-06-30	CI
Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-06	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-04	CI
Hofseth BioCare ASA Approves Election Amy Novogratz to Its Board of Directors	21-12-03	CI
Hofseth Biocare Gets US Dietary Ingredient Status for Nutritional Suplements Extracted from Salmon	21-12-02	MT
Hofseth Biocare ASA Successfully Receive New Dietary Ingredient Status from the US FDA	21-12-01	CI

Chart Hofseth BioCare ASA

Duration

Period

More charts

Company Profile

Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Companyâs business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Sector

Food Processing

Calendar

2024-08-29 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Food Processing

	1st Jan change	Capi.
HOFSETH BIOCARE ASA	-14.89%	82.33M
NESTLÉ S.A.	-2.02%	277B
MONDELEZ INTERNATIONAL, INC.	-1.52%	95.68B
KRAFT HEINZ	-3.06%	43.53B
THE HERSHEY COMPANY	+10.17%	41.54B
DANONE	+1.60%	41.59B
GENERAL MILLS, INC.	+7.20%	39.42B
ARCHER-DANIELS-MIDLAND COMPANY	-16.81%	29.71B
NESTLÉ INDIA LIMITED	-7.27%	28.5B
ASSOCIATED BRITISH FOODS PLC	+14.53%	25.64B

Other Food Processing